empty
 
 

21.01.201501:01:48UTC+00J&J's quarterly sales hurt by stronger dollar

American company Johnson & Johnson reported lower-than-expected quarterly sales as a stronger dollar offset higher sales of the Band-Aid maker's new drugs and older treatments.

International sales fell about 7% to $9.65 billion in the 4th quarter, accounting for about half of its total sales.

The dollar surged nearly 13 percent against major currencies in 2014, its strongest performance since 1997.

Revenue in J&J's pharmaceuticals business rose 9.6% in the quarter, driven by higher sales of new drugs such as hepatitis C drug Olysio and older treatments such as psoriasis drug Stelara.

The business accounts for about 44% of the company's total sales.

However, sales in its second largest business, J&J devices, dropped 9%.

The company's net profit fell about 28 percent to $2.52 billion, or 89 cents per share, including a $1.1 billion charge related to its acquisition of Synthes Inc.

Excluding items, J&J earned $1.27 per share. Total sales fell 0.6 percent to $18.25 billion. J&J forecast a profit of $6.12-$6.27 per share for 2015.

  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    JOIN CONTEST
  • Chancy Deposit
    Deposit your account with $3,000 and get $6000 more!
    In December we raffle $6000 within the Chancy Deposit campaign!
    Get a chance to win by depositing $3,000 to a trading account. Having fulfilled this condition, you become a campaign participant.
    JOIN CONTEST
  • Trade Wise, Win Device
    Top up your account with at least $500, sign up for the contest, and get a chance to win mobile devices.
    JOIN CONTEST
  • 30% Bonus
    Receive a 30% bonus every time you top up your account
    GET BONUS


Can't speak right now?
Ask your question in the chat.
Widget callback